Combination therapy for the treatment of gastrointestinal stromal tumors

• 收藏
• 分享

专利权人:

LLC;Deciphera Pharmaceuticals

发明人:

FLYNN, Daniel L.,SMITH, Bryan D.,GUPTA, Anu

申请号：

AU2019215081

公开号：

AU2019215081A1

申请日:

2019.01.31

申请国别(地区):

AU

年份:

2020

代理人:

摘要：

The present disclosure relates to the use of l-[4-bromo-5-[l-ethyl-7-(methylamino)-2- oxo-l,2-dihydro-l,6-naphthyridin-3-yl]-2-fluorophenyl]-3-phenylurea or l-(5-(7-amino-l- ethyl-2-oxo-l,2-dihydro-l,6-naphthyridin-3-yl)-4-bromo-2-fluorophenyl)-3-phenylurea, or a pharmaceutically acceptable salt thereof, in combination with a MAPKAP kinase inhibitor for the treatment of cancers, including c-KIT-mediated cancers, such as GIST.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/